These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2872158)

  • 1. Purification of a protein with hypoglycaemic effect from Bordetella pertussis cell extracts.
    Kishore M; Baxi AJ; Ramakrishnan P
    Indian J Med Res; 1986 Feb; 83():139-47. PubMed ID: 2872158
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and preliminary characterization of agglutinogen 3 from Bordetella pertussis.
    Fredriksen JH; Frøholm LO; Paulsen BS
    Dev Biol Stand; 1985; 61():187-96. PubMed ID: 2872104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental relation between leukocytosis and other factors of Bordetella pertussis].
    Ruiz Puente J; Rivera Rivera D; González Pacheco M
    Salud Publica Mex; 1981; 23(6):613-20. PubMed ID: 6278659
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiolabelling of Bordetella pertussis envelope proteins by the 125 I-lactoperoxidase method.
    Gow JA; Parton R; Wardlaw AC
    Microbios; 1976; 15(61-62):209-19. PubMed ID: 189162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bordetella pertussis extract induces increase in the activities of glycolytic enzymes in mouse liver.
    Shyamala S; Sengupta SR; Ramakrishnan P
    Indian J Biochem Biophys; 1992 Oct; 29(5):445-7. PubMed ID: 1289237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic reaction of Bordetella pertussis and leukocytic reaction in mice].
    Walecki H; Sitek K
    Med Dosw Mikrobiol; 1966; 18(2):111-5. PubMed ID: 4287625
    [No Abstract]   [Full Text] [Related]  

  • 9. Further contributions to an improved pertussis vaccine: I. Molecular mechanisms of pertussis toxin.
    Aktories K; Jakobs KH; Robbel L
    Behring Inst Mitt; 1984 Nov; (76):106-9. PubMed ID: 6098260
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis.
    Brennan MJ; Li ZM; Shahin RD; Burns DL; Nguyen NY; Liu TY; Gray MC; Hewlett EL; Manclark CR
    Tokai J Exp Clin Med; 1988; 13 Suppl():211-5. PubMed ID: 2908522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Bordetella pertussis on rosette-forming cells present in the peritoneal fluids of mice.
    Fishel CW; Pross SH; Klein TW
    J Reticuloendothel Soc; 1976 Feb; 19(2):97-108. PubMed ID: 177778
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages].
    Tiukavkina SIu; Moskalenko EP
    Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization.
    Yajima M; Hosoda K; Kanbayashi Y; Nakamura T; Nogimori K; Mizushima Y; Nakase Y; Ui M
    J Biochem; 1978 Jan; 83(1):295-303. PubMed ID: 203574
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pertussis toxin--islet-activating protein (IAP)].
    Ui M; Katada T; Nogimori K; Tamura M; Yajima M
    Tanpakushitsu Kakusan Koso; 1986 Mar; 31(4 Suppl):300-23. PubMed ID: 2872698
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunomodulation by Bordetella pertussis: antiviral effects.
    Winters AL; Baggett DW; Lee JD; Sloan GL; Lemmon RD; Stinson RS
    Dev Biol Stand; 1985; 61():233-40. PubMed ID: 2872109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of islets-activating protein of Bordetella pertussis on glucagon release from mice isolated islets.
    Kikkawa R; Haneda M; Hatanaka I; Shigeta Y; Ueno T; Okuno M
    Horm Metab Res; 1981 Dec; 13(12):713-4. PubMed ID: 6119285
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
    Novotny P; Chubb AP; Cownley K; Charles IG
    Dev Biol Stand; 1991; 73():243-9. PubMed ID: 1778316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological studies with the desoxycholate extract of Bordetella pertussis according to Barta].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):461-9. PubMed ID: 4294232
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunobiological properties of Bordetella pertussis].
    Kopacka B
    Pediatr Pol; 1972; 47(3):361-70. PubMed ID: 4336329
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.